Reduction observed in RSV-related hospitalizations in adults aged ≥60 years 1 An observed reduction in major adverse ...

Respiratory syncytial virus (RSV) vaccines were an estimated 79% effective against dangerous virus-related blood clots among ...

Antibodies harvested from the blood of paediatricians are up to 25 times better at protecting against the common respiratory ...

Cook Government to expand access to free respiratory syncytial virus (RSV) vaccines to older Western Australians in ...

Beyfortus is not a vaccine. It’s a monoclonal antibody designed to help protect babies from serious RSV lung infection during ...

Clinicians underutilize RSV testing in adults with respiratory or cardiac exacerbations, potentially obscuring the true burden of disease.

The Royal Australian College of GPs (RACGP) has welcomed the Western Australian Government's announcement that older Western Australians living in ...

Adults hospitalized with a respiratory syncytial virus infection have an increased risk for cardiorespiratory events in the weeks afterward, according to a retrospective analysis.

From early failures to prefusion F protein breakthroughs, RSV vaccine development has accelerated, reshaping prevention strategies for infants and older adults.

Human challenge trials offer a complementary approach. By safely and deliberately exposing healthy adult volunteers to a well characterised virus under controlled conditions, researchers can generate ...

Here’s our weekly round-up of what illnesses are spreading the most in Metro Detroit communities, according to our local ...

Respiratory infection risk increases during winter due to a combination of environmental factors, seasonal immune changes, viral transmission dynamics, and behavioral shifts that collectively favor ...